Q3 FY2026 · ended Sep 30, 2026 · Revenue $455.86M, +25.3% YoY · Filed Nov 5, 2026
LifeStance Health Group, Inc. (LFST) files with the SEC under industry code 8000, Services-Health Services. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $455.9 million and net income of $22.4 million. Free cash flow was $22.4 million. As of Sep 30, 2026 it held $218.8 million in cash and investments and $477.4 million in total debt.
Revenue
$455.86M
+25.3% vs year-ago quarter
Net income
$22.39M
+1978.5% vs year-ago quarter
Operating cash flow
$37.02M
+35.7% vs year-ago quarter
Free cash flow
$22.36M
+31.6% vs year-ago quarter
EPS
—
Dividend per share
None
Shares outstanding
380.19M
-2.3% vs year-ago quarter
Net cash
$-258.55M
Q3 FY2026
Operating margin
6.2%
TTM
Company profile
- Industry
- Services-Health Services (SIC 8000)
- Listed as
- LFST (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Scottsdale, AZ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1845257
Other Services-Health Services companies
- Privia Health Group, Inc. PRVA
- GeneDx Holdings Corp. WGS
- Pennant Group, Inc. PNTG
- U S Physical Therapy Inc /NV USPH
- InnovAge Holding Corp. INNV
- Omada Health, Inc. OMDA
- P3 Health Partners Inc. PIII
- Alps Group Inc ALPS
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $455.9M | $435.4M | $403.5M | $382.2M | $363.8M |
| Operating income | $33.1M | $30.7M | $22.3M | $18.1M | $7.4M |
| Net income | $22.4M | $23.6M | $14.2M | $11.7M | $1.1M |
| Operating cash flow | $37.0M | $99.9M | $33.1M | $57.6M | $27.3M |
| Free cash flow | $22.4M | $87.9M | $22.3M | $46.6M | $17.0M |
| Total assets | $2.2B | $2.2B | $2.1B | $2.2B | $2.1B |
| Total liabilities | $693.9M | $704.3M | $668.5M | $682.9M | $656.2M |
| Stockholders' equity | $1.5B | $1.5B | $1.5B | $1.5B | $1.5B |
| Cash and investments | $218.8M | $225.9M | $194.8M | $248.6M | $203.9M |
| Total debt | $477.4M | $476.2M | $478.9M | $476.8M | $476.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 16, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Other events
|
Sep 11, 2026 | Sep 9, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Aug 6, 2026 | Aug 6, 2026 |
All 502 LifeStance Health Group, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.